However, in non-small cell lung cancer (NSCLC), histone Kla modification has been found to suppress glucose uptake and glycolysis in tumor cells [48], indicating the existence of more extensive and sophisticated regulatory mechanisms through which tumor cells utilize Kla-mediated modifications to orchestrate metabolic pathways. This evidence concerns the gene KL and neoplasm.